HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Job losses at Glen Dimplex big blow for Louth – Butterly
The loss of 70 jobs in Glen Dimplex in Dunleer, Co. Louth is a major blow to the local community,…
30th January 2025Tánaiste appoints Emer Currie TD Deputy Government Whip
The Tánaiste Simon Harris has appointed Emer Currie TD as the Deputy Government Whip alongside the Junior Minister appointments announced…
29th January 2025Rollout of free HRT key women’s health priority in Programme for Government – Boland
The Programme for Government ensures the rollout of free HRT and also commits to increasing the network of menopause clinics…
16th January 2025